Jack W. Singer
2012
In 2012, Jack W. Singer earned a total compensation of $1.1M as Executive Vice President, Chief Scientific Officer, Interim Chief Medical Officer and Global Head of Translational Medicine at CTI BioPharma, a 9% decrease compared to previous year.
Compensation breakdown
| Bonus | $203,000 |
|---|---|
| Salary | $340,000 |
| Stock Awards | $536,147 |
| Other | $42,579 |
| Total | $1,121,726 |
Singer received $536.1K in stock awards, accounting for 48% of the total pay in 2012.
Singer also received $203K in bonus, $340K in salary and $42.6K in other compensation.
Rankings
In 2012, Jack W. Singer's compensation ranked 5,675th out of 11,487 executives tracked by ExecPay. In other words, Singer earned more than 50.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,675 out of 11,487 | 51st |
Division Manufacturing | 2,013 out of 4,253 | 53rd |
Major group Chemicals And Allied Products | 490 out of 1,198 | 59th |
Industry group Drugs | 330 out of 920 | 64th |
Industry Pharmaceutical Preparations | 257 out of 700 | 63rd |
Source: SEC filing on July 29, 2015.
Singer's colleagues
We found seven more compensation records of executives who worked with Jack W. Singer at CTI BioPharma in 2012.
2012
James Bianco
CTI BioPharma
Chief Executive Officer
2012
Craig Philips
CTI BioPharma
Former President
2012
Louis Bianco
CTI BioPharma
Executive Vice President, Finance and Administration
2012
Daniel Eramian
CTI BioPharma
Former Executive Vice President Corporate Communications
2012
Steven Benner
CTI BioPharma
Chief Medical Officer
2012
Translational Benner
CTI BioPharma
Chief Medical Officer
2012
Matthew Plunkett
CTI BioPharma